Page last updated: 2024-11-02

oxonic acid and Cancer, Second Primary

oxonic acid has been researched along with Cancer, Second Primary in 11 studies

Oxonic Acid: Antagonist of urate oxidase.

Research Excerpts

ExcerptRelevanceReference
"The involvement of S-1 chemotherapy in ATLL development suggests that a test for HTLV-1 antibody should be performed before treatment and that S-1 should not be administered in HTLV-1 positive patients with head and neck carcinoma."1.46Adult T-cell leukemia/lymphoma in patients with head and neck cancer after S-1 chemotherapy. ( Kurono, Y; Matushita, K; Nagano, H, 2017)
"He had no evidence of recurrence of gastric cancer, although he had a continuous poor appetite due to TS-1."1.36[Secondary chronic myelogenous leukemia following postoperative TS-1 therapy for advanced gastric cancer]. ( Imai, T; Machida, T; Shima, Y; Uemura, Y, 2010)
"Despite a diagnosis of cStage IV gastric cancer (cN2, cH0, cM0, cT3 (SE), cP1), we preferentially performed a non-curative surgery to avoid stenosis or bleeding by tumor invasion."1.36[Long-term disease-free survival following multimodal treatment in a patient with curatively unresectable advanced gastric cancer with metachronous liver metastasis]. ( Fukumoto, I; Fukumoto, K; Ishida, E; Itani, K; Kanemitsu, D; Kassai, K; Kobayashi, Y; Miyagaki, T; Nakase, Y; Sakamoto, K; Soga, K; Takagi, T; Takenaka, S; Yanagida, K, 2010)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (27.27)29.6817
2010's8 (72.73)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kitani, Y2
Kubota, A1
Furukawa, M1
Hori, Y1
Nakayama, Y1
Nonaka, T1
Mizoguchi, N1
Hatakeyama, H1
Oridate, N1
Furuya, K1
Tokumitsu, Y1
Yoshino, S1
Inoue, Y1
Iida, M1
Tamesa, T1
Takeda, S1
Ueno, T1
Hazama, S1
Nagano, H2
Kurono, Y1
Matushita, K1
Nishiguchi, R1
Kim, DH1
Honda, M1
Sakamoto, T1
Hashimoto, K1
Suzuki, M1
Uemura, Y1
Imai, T1
Machida, T1
Shima, Y1
Takagi, T1
Nakase, Y1
Fukumoto, K1
Miyagaki, T1
Ishida, E1
Kobayashi, Y1
Soga, K1
Kanemitsu, D1
Kassai, K1
Sakamoto, K1
Takenaka, S1
Yanagida, K1
Itani, K1
Fukumoto, I1
Matsumoto, K1
Kitanaka, A1
Uemura, M1
Waki, F1
Fukumoto, T1
Ohnishi, H1
Kubota, Y1
Ishida, T1
Kashima, Y1
Adachi, T1
Hara, N1
Sohtome, I1
Shirasaka, T1
Tsunezuka, Y1
Oda, M1
Moriyama, H1
Higuchi, M1
Nishinaka, H1
Yamano, Y1

Other Studies

11 other studies available for oxonic acid and Cancer, Second Primary

ArticleYear
Impact of combined modality treatment with radiotherapy and S-1 on T2N0 laryngeal cancer: Possible improvement in survival through the prevention of second primary cancer and distant metastasis.
    Oral oncology, 2017, Volume: 71

    Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemoradiotherapy; Drug Combination

2017
[A Case of a Submucosal Tumor-Like Gastric Cancer That Needed to Be Distinguished from Gastric Metastasis of Rectal Cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12

    Topics: Antimetabolites, Antineoplastic; Drug Combinations; Gastric Mucosa; Humans; Male; Middle Aged; Neopl

2015
Adult T-cell leukemia/lymphoma in patients with head and neck cancer after S-1 chemotherapy.
    Auris, nasus, larynx, 2017, Volume: 44, Issue:2

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; C

2017
Squamous cell carcinoma of the extrahepatic bile duct with metachronous para-aortic lymph node metastasis successfully treated with S-1 plus cisplatin.
    BMJ case reports, 2016, Dec-08, Volume: 2016

    Topics: Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Carcinoma, Squ

2016
[A case of metachronous liver metastasis from gastric cancer treated with multidisciplinary therapy including hepatectomy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12

    Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Catheter Ablation; Cis

2009
[Secondary chronic myelogenous leukemia following postoperative TS-1 therapy for advanced gastric cancer].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2010, Volume: 51, Issue:7

    Topics: Aged; Antimetabolites, Antineoplastic; Benzamides; Drug Combinations; Fatal Outcome; Gastrectomy; Hu

2010
[Long-term disease-free survival following multimodal treatment in a patient with curatively unresectable advanced gastric cancer with metachronous liver metastasis].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12

    Topics: Antimetabolites, Antineoplastic; Catheter Ablation; Combined Modality Therapy; Disease-Free Survival

2010
S-1 induced secondary acute erythroid leukemia with a chromosome inv(12)(p13;q13).
    World journal of gastroenterology, 2011, Nov-07, Volume: 17, Issue:41

    Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Chromosome Inversion; Drug Combinatio

2011
[A case of successful S-1 alternate-day administration for far-advanced remnant gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:3

    Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Fatal Outcome; Gastric Stump;

2012
[A case of a second cancer of metachronous multiple primary non-small cell lung cancer successfully treated with TS-1 and CDDP chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:5

    Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinom

2006
[A case of chronic myeloid leukemia following TS-1 therapy for advanced gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:13

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Drug

2006